Menu
About Us
Our Purpose, Mission and Values
Our Story So Far
Our Leadership Team
Videos & Presentations
Lung Cancer
Key Statistics
Our LungLB® Test
Informative Videos
News
RNS Announcements
Press Inquiries
Investors
Description of the Business
Directors
Corporate Governance
Company Information
Shareholder Information
Financial Information
Advisors
Contact Us
close
Presentation: Half-year report for the six months ended 30 June 2024
September 3, 2024
Interim results to 30 June 2024.
Recent Presentations
Presentation: Half-year report for the six months ended 30 June 2024
September 3, 2024
Lung Life AI's CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB®
June 25, 2024
Presentation: Audited results for the year ended 31 December 2023
April 8, 2024
Media
»
Presentation: Half-year report for the six months ended 30 June 2024
LungLife AI licensure/accreditation information posted here.
© 2023 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.
close
bars
linkedin
chevron-down
LungLife AI licensure/accreditation information posted here.